CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

NCT04620681 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Secondary Acute Myeloid Leukemia

Interventions

BIOLOGICAL: CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
DRUG: Standard of Care Chemotherapy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute